T

The Geneva Foundation

Nonprofit advancing military medicine via research

Clinical Research Coordinator

Full-TimeUpdated on 10/4/2026
$70k - $80k
Mid
Bachelor's
Columbia, SC, USA
In Person

About the job

Requirements
  • A bachelor's degree or equivalent work experience is required.
  • Two to four years of clinical research experience is preferred.
  • Two to four years of nonprofit, research, or healthcare experience is desired.
  • Demonstrated competence in oral and written communication is required.
  • The candidate must be organized and attentive to detail.
  • The candidate must be flexible with changing priorities and able to communicate diplomatically and professionally.
  • At least intermediate computer skills with Excel and other Microsoft Office software are required.
  • Knowledge of Code of Federal Regulations, Good Clinical Practice, and International Council for Harmonisation guidelines is required.
Responsibilities
  • Promote the safety and confidentiality of research participants at all times.
  • Adhere to Occupational Safety and Health Administration requirements, Good Clinical Practices, Good Laboratory Practices, and infection control procedures.
  • Plan and coordinate the initiation of research study protocols and implementation of operating policies and procedures.
  • Plan, implement, and maintain data collection and analysis systems in support of research protocols; coordinate collection and analysis of research data as needed.
  • Recruit, instruct, and coordinate research subjects and/or volunteers in accordance with study objectives and work scope.
  • Coordinate day-to-day activities of technical support staff engaged in carrying out research or clinical protocols, as appropriate; perform aspects of research protocols as required by program objectives.
  • Organize and facilitate meetings, conferences, and other events associated with research activities; perform and/or coordinate outreach activities as appropriate to research objectives.
  • Document all correspondence and communication pertinent to the research.
  • Communicate effectively with the Principal Investigator, site personnel, research participants, The Geneva Foundation, and the funding organization.
  • Comply with rules and regulations applicable to the assigned duty station.
  • Create and adhere to a data quality and quality assurance plan.
  • Assist with interim and annual reports; serve as the primary liaison at the data collection site and explain the project to military personnel associated with the study.
  • Perform basic study-related procedures proficiently.
  • Complete required and applicable research training.
  • Maintain and update applicable regulatory documentation for IACUC or IRB, including protocols, approvals, amendments, and modifications, and communications with the sponsor or other federal or regulatory offices, including prior approvals and changes in scope.
Desired Qualifications
  • Certification or licensure as an Athletic Trainer (ATC), Physical Therapist Assistant (PTA), or Physical Therapist (PT) is preferred but not required.
  • Experience working in orthopedic, sports medicine, rehabilitation, or clinical research settings is preferred.
  • Familiarity with outcome assessments and patient functional evaluations is preferred.
  • Certification or licensure in a relevant clinical discipline, such as ATC, PTA, or PT, is a plus but not required to apply.

About the company

The Geneva Foundation advances military medicine to improve the health of service members and the communities they serve through research, development, and education. It leverages 30 years of scientific and program-management expertise to support federal grants, federal contracts, industry-sponsored clinical trials, and educational services. It differentiates itself as a 501(c)(3) nonprofit focused specifically on military health and acts as a bridge among service members, researchers, industry sponsors, and healthcare providers. Its goal is to ensure optimal health for service members and communities by turning medical knowledge into practice.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Tacoma, Washington

Founded

1993

Get referred to The Geneva Foundation

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • May 2026 NeuroCatch partnership adds cognitive-health research for warfighter readiness.
  • April 2026 DHA award brought $488,276 for breast-cancer research through March 2029.
  • June 2026 RESPOND-US membership expands Geneva into trauma and emergency readiness networks.

What critics are saying

  • DoD funding concentration makes Geneva hostage to budget shifts and contract renewals.
  • Research intermediary model depends on external partners like NeuroCatch and Philips for pipeline.
  • A single federal contract collapse could cripple operations and eliminate mission relevance.

What makes The Geneva Foundation unique

  • 30+ years advancing military medicine through DoD-aligned research and deployment.
  • Master CRADA with Defense Health Agency streamlines research at military treatment facilities.
  • Deep portfolio spans AREVA, MIRROR, TSNRP, REC^3^ON, and 4DBio3 programs.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Health Savings Account/Flexible Spending Account

Disability Insurance

Life Insurance

Paid Vacation

Paid Holidays

Professional Development Budget

Company News

TMX Newsfile
May 12th, 2026
NeuroCatch Inc. announces strategic partnership with The Geneva Foundation to advance cognitive health research for military personnel.

NeuroCatch Inc. announces strategic partnership with The Geneva Foundation to advance cognitive health research for military personnel. Groundbreaking collaboration supports cutting-edge research to improve brain health assessment for military service members. Vancouver, British Columbia-(Newsfile Corp. - May 12, 2026) - NeuroCatch Inc., a leader in objective cognitive brain health assessment, today announced a research partnership with The Geneva Foundation (Geneva), a nonprofit organization dedicated to advancing military medical research and warfighter readiness. Through this collaboration, NeuroCatch's technology will support innovative research initiatives aimed at improving cognitive health outcomes for military service members. The NeuroCatch Platform is an objective neurophysiological brain function assessment tool that delivers rapid, evidence-based evaluations of cognitive brain health at the point of care in approximately six minutes. Using electroencephalography (EEG) technology, it measures key brain vital signs - including attention, auditory sensation, and cognitive processing - providing clinicians and researchers with precise, actionable data to support informed decision-making and personalized care. Geneva brings extensive expertise in advancing military medical research programs and a strong commitment to warfighter health. This partnership reflects a shared dedication to deploying innovative tools that advance cognitive resilience and performance among military personnel. "We are honored to partner with The Geneva Foundation in advancing research that directly supports our military service members," said Derek Norsworthy, CEO of NeuroCatch Inc. "Objective measurement of brain function is critical to improving how cognitive health is assessed and monitored in high-performance and high-risk environments. We are proud to contribute and look forward to a lasting and growing partnership." "We are excited to partner with NeuroCatch Inc. to bring innovative, objective brain health technologies into military research," said Elise Huszar, President and CEO of The Geneva Foundation. "This collaboration aligns with our mission to advance evidence-based solutions that enhance warfighter readiness and resilience. By integrating cutting-edge technology into our research portfolio, Geneva is better positioned to support the long-term health and performance outcomes of Service members." About the NeuroCatch Platform The NeuroCatch Platform is available for sale in the U.S. It is not intended as a stand-alone or adjunctive diagnostic device and does not identify the presence or absence of clinical diagnoses. The platform is intended to be used in conjunction with other cognitive assessments and is not a diagnostic tool for any specific brain health condition. About The Geneva Foundation Geneva is a mission-driven organization with 30+ years of experience advancing operationally relevant, unique research aligned with military health priorities to strengthen mission success and force readiness. Geneva accelerates military medical research and development into fielded capability, bridging the gap between discovery and deployment to deliver solutions that meet evolving operational demands. With deep expertise in research operations, government contracting, and strategic collaboration, Geneva enables the transition from research investment to measurable operational impact. Peter Romeo Email: [email protected] Phone: 1-844-847-1264 NeuroCatch Inc. Unit 1009, City Centre 3 13761 96 Avenue, Surrey, BC V3V 0E8 Canada Ready to announce with confidence? Send us a message and a member of our TMX Newsfile team will contact you to discuss your needs.

RIVANNA
Sep 8th, 2025
RIVANNA awarded $3 million CDMRP grant to develop military-optimized ultrasound guidance system for spinal interventions

RIVANNA awarded $3 million CDMRP grant to develop military-optimized ultrasound guidance system for spinal interventions.

Kitware
Feb 7th, 2024
Developing AI Algorithms to Assist with Medical Triage

Kitware, in collaboration with Soar Technology and The Geneva Foundation, will develop AI algorithms paired with rule-based symbolic predictions that provide decision support targeted at life-saving interventions for injuries, including hemorrhage, pneumothorax, and airway obstructions.

Yahoo Finance
Oct 24th, 2023
Oref, Mtec, Dod Select Recipients Of $2 Million Research Award Collaboration

Recipients will utilize the funds for research leading to the advancement of solutions to accelerate return-to-readiness for Service Members experiencing musculoskeletal injuries.ROSEMONT, Ill., Oct. 24, 2023 /PRNewswire-PRWeb/ -- The Orthopaedic Research and Education Foundation (OREF), in collaboration with the Medical Technology Enterprise Consortium (MTEC) and the Department of Defense's (DOD) U.S. Army Medical Research and Development Command's (USAMRDC) Military Operational Medicine Research Program (MOMRP), today announced selection for recipients of the OREF/MTEC Request for Project Proposals entitled, "MTEC-23-02-MSKI, Solutions to Accelerate Return-to-Readiness following Musculoskeletal Injuries." The program provides $2 million in research and development funding. OREF is contributing $100,000 toward the awards, which was made possible by a generous gift from The Aircast Foundation, a private foundation committed to promoting and supporting excellence in scientific and clinical research and education in the area of orthopaedic medicine. The remainder of the funding is provided by the DOD.Awards were made to the Henry Jackson Foundation for the Advancement of Military Medicine Inc., which will receive $1.3 million for its study addressing dynamic gait-synchronous neuromuscular electrical stimulation following anterior cruciate ligament (ACL) reconstruction, and the Geneva Foundation, which will receive over $700,000 for its study addressing the development of a dynamic three-dimensional knee assessment medical device to accelerate return to readiness from knee pain. Studies will commence in September 2023, and it is expected that they will conclude no later than September 2026."OREF is committed to improving care and outcomes for all patients, including those serving in our military forces," noted OREF Trustee Colonel James R

Geneva USA
Sep 22nd, 2023
Geneva Leads New $9.8M+ Research Program to Revolutionize Military Musculoskeletal Injury Management

Bethesda, MD - The Geneva Foundation, a leading nonprofit dedicated to advancing military medicine, has received $9.84 million to pioneer a deployment-limiting musculoskeletal conditions (DLMC) research program.